Real-Life Benefit of Omalizumab in Improving Control of Bronchial Asthma During COVID-19 Pandemic

Biologic therapy is recommended by Global Initiative for Asthma (GINA) guidelines in asthma patients not controlled with maximal inhaled therapy corresponding to GINA step 4. Omalizumab is an anti- immunoglobulin E (IgE) monoclonal antibody and the first biological available for the add-on treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Leru, Polliana Mihaela, Anton, Vlad Florin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371356/
https://www.ncbi.nlm.nih.gov/pubmed/34422507
http://dx.doi.org/10.7759/cureus.17268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371356/
https://www.ncbi.nlm.nih.gov/pubmed/34422507
http://dx.doi.org/10.7759/cureus.17268

Ejemplares similares